NCT00546702View on ClinicalTrials.gov

Glulisine + Lantus in Type I Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

142

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

Insuline Glulisine

Trial Locations (1)

Unknown

Sanofi-aventis, Moscow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY